Views
4 years ago

99 - D Serrani - Agosto 2016

  • Text
  • Depresion
  • D
  • Alcoholico
  • Nota
  • Psico
  • Valores
  • Depression
  • Grupos
  • Participantes
  • Estudio
  • Pacientes
  • Placebo
  • Vitamin
  • Vitamina
Efecto de suplementación con vitamina D sobre depresión en pacientes con hígado graso no alcohólico

Dr. Daniel

Dr. Daniel Serrani min D supplementation prevent winter-time blues? A randomised trial among older women. J Nutr Health Aging 2006; 10, 151–3. • Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J., Feron, F. Vitamin D3 and brain development. Neuroscience 2003; 118, 641-53. • Eyles, D., Smith, S., Kinobe, R., Hewison, M., McGrath, J. J. Distribution of the vitamin D receptor and 1alpha-hydroxylase in human brain. J Chem Neuroanat. 2005; 29:21–30. • Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R. A., Bugianesi, E., & Gastaldelli, A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013, 5(5), 1544- 1560. • Ganji, V., Milone, C., Cody, M. M. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med. 2010; 3, 29. • Garcion, E., Wion-Barbot, N., Montero- Menei, C. N., et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002; 13(3), 100-105. • Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012; 66:1072–4. • Haukeland, J. W., Damäs, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 2006; 44, 1167–74. • Hedelin, M., Löf, M., Olsson, M. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population. BMC Psychiatry 2010; 10, 38. • Högberg, G., Gustafsson S. A., Hällström, T. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatr 2012; 101(7), 779-783. • Holick, M. F. Vitamin D deficiency. N Engl J Med. 2007; 357(3), 266-281. • Holick, M. F., Chen, T. C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87(4), 1080S-1086S. • Hoogendijk, W. J., Lips, P., Dik, M. G. eDepression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008; 65(5), 508-512. • Jablonski, K. L., Chonchol, M., Pierce, G. L., Walker, A. E., Seals, D. R. 25-Hydroxyvitamin D deficiency is associated with inflammationlinked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011; 57, 63–9. • Kjærgaard, M., Waterloo, K., Wang, C. E. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomized clinical trial. Br J Psychiatry 2012; 201(5), 360-368. • Kuningas, M., Mooijaart, S. P., Jolles, J. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging. 2009; 30(3), 466- 473. • Llewellyn, D.J., Lang, I. A., Langa, K. M. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010; 170(13), 1135-1141. • Marí, M., Morales, A., Colell, A., García- Ruiz, C., & Fernandez-Checa, J. C. Oxidative Stress in Nonalcoholic Fatty Liver Disease. In Studies on Hepatic Disorders (pp. 279-308). Springer International Publishing, 2015. • May, H. T., Bair, T. L., Lappé, D. L., Anderson, J. L., Horne, B. D., Carlquist, J. F., Muhlestein, J. B. Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J. 2010; 159(6), 1037-43. • McCann, J. C., Ames, B. N. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 2008; 22, 982–1001. • McGrath, J., Eyles, D., Mowry, B. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr Res. 2003; 63(1-2), 73-78. • McGrath, J., Saari, K., Hakko, H. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res. 2004; 67(2-3), 237-245. • Newmark, H. L., Newmark, J. Vitamin D and Parkinson’s Disease- A hypothesis. Mov Disord 2007; 22:461–468. • Nishida, N., Yada, N., Hagiwara, S., Sakurai, T., Kitano, M., & Kudo, M. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non‐alcoholic fatty liver disease. Journal of gastroenterology and hepatology 2016, 1440-1746. • Obradovic, D., Gronemeyer, H., Lutz, B., Rein, T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006; 96, 500–509. • Pan, A., Lu, L., Franco, O.H. Association between depressive symptoms and 25- hydroxyvitamin D in middle-aged and elderly Chinese. J. Affect Disord. 2009; 118(1-3), 240-243. • Peterson, C. A., Heffernan, M. E. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH) D concentrations in healthy women. J Inflamm (Lond) 2008; 5, 10. • Pittas, A. G., Harris, S. S., Stark, P. C., Dawson-Hughes, B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30, 980–6. • Przybelski, R. J., Binkley, N. C. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007; 460, 202–5. • Sepehrmanesh, Z., Kolahdooz, F., Abedi, F., Mazroii, N., Assarian, A., Asemi, Z., & Esmaillzadeh, A. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. The Journal of nutrition 2015, jn218883. • Smith MP, Fletcher-Turner A, Yurek DM, et al. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006; 31(4), 533-539. • Snijder, M. B., van Dam, R. M., Visser, M. Adiposity in relation to vitamin D status and parathyroid hormone levels: a populationbased study in older men and women. J Clin Endocrinol Metab 2005; 90, 4119–23. • Stokes, C. S., Grünhage, F., Baus, C., Volmer, D. A., Wagenpfeil, S., Riemenschneider, M., & Lammert, F. Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clinical Nutrition 2016, 35(4), 950-957. • Uchihara, M., Izumi, N. High-sensitivity C- reactive protein (hs-CRP): A promising biomarker for the screening of non-alcoholic steatohepatitis (NASH) Nihon Rinsho. 2006; 64:1133-8. • von Hurst, P. R., Stonehouse, W., Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomized, placebocontrolled trial. Br J Nutr. 2010; 103, 549. • Williams, K. H., Shackel, N. A., Gorrell, M. D., McLennan, S. V., & Twigg, S. M. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocrine reviews 2012, 34(1), 84-129. • Youssef, N. A., Abdelmalek, M. F., Binks, M., Guy, C. D., Omenetti, A., Smith, A. D., & Suzuki, A. Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver International 2013, 33(7), 1062- 1070. • Zehnder, D., Bland, R., Williams, M. C. Extrarenal expression of 25-hydroxyvitamin D (3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86, 888–94. 30 // EDITORIAL SCIENS

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015